Pierre Fabre Pharma SA
Pierre Fabre Pharma SA is a Originators company based in Allschwil (Basel-Landschaft) recorded by Swissmedic as the authorisation holder for 27 human medicines. That places it 69 of 334 authorisation holders in Switzerland. Its portfolio is concentrated in Synthetika.
Key facts
| Sector | Originators |
|---|---|
| City | Allschwil |
| Canton | Basel-Landschaft |
| Authorisation holder | Yes |
| Medicines | 27 |
| Founded | Not available |
| Employees | 51-200 |
| Parent group | Laboratoires Pierre Fabre |
| Activity | Not available |
| Website | Not available |
Medicines authorised in Switzerland
Pierre Fabre Pharma SA is recorded by Swissmedic as the authorisation holder for 27 human medicines. The table shows 27 of them with product code and dispensing category.
Portfolio by product code
Portfolio by dispensing category
27 of 27 authorisations
| Name | Authorisation number | Dispensing category | ATC | First authorised |
|---|---|---|---|---|
| Alopexy 2% | 51853 | D | D11AX01 | 1993-11-25 |
| Alopexy 5% | 67747 | D | D11AX01 | 2020-09-28 |
| Anesderm | 56682 | B | N01BB20 | 2006-09-26 |
| Braftovi 50 mg | 66795 | A | L01EC03 | 2019-11-01 |
| Carbolevure | 37456 | D | A07BA51 | 1974-04-23 |
| Clarelux | 60393 | B | D07AD01 | 2010-12-03 |
| Curakne 10 mg | 56885 | A | D10BA01 | 2004-10-05 |
| D3 VitaCaps 24 | 68197 | B | A11CC05 | 2022-08-12 |
| Dexeryl | 60404 | D | D02AX | 2011-01-14 |
| Ebvallo | 69052 | A | L01XL09 | 2024-05-03 |
| Ektoselen | 39242 | D | - | 1975-07-30 |
| Gyno-Tardyferon | 39859 | D | B03AD03 | 1976-07-16 |
| Hemangiol 3.75 mg/ml | 61214 | B | C07AA05 | 2014-08-15 |
| Mektovi 15 mg | 66907 | A | L01EE03 | 2019-11-01 |
| Monofer 100 mg / 1 ml | 67001 | B | B03AC | 2019-08-26 |
| Mycoster | 59959 | B | D01AE14 | 2010-05-18 |
| Navelbine | 51783 | A | L01CA04 | 1995-12-27 |
| Navelbine 20 mg | 56774 | A | L01CA04 | 2004-08-03 |
| Nerlynx 40 mg | 67293 | A | L01EH02 | 2020-03-20 |
| Nisulid 100 mg | 52001 | B | M01AX17 | 1992-05-19 |
| Nisulid 100 mg | 52002 | B | M01AX17 | 1992-05-19 |
| Obgemsa 75 mg | 69983 | B | G04BD15 | 2025-08-20 |
| Permixon | 52759 | D | G04CX02 | 1995-04-21 |
| Structum 500 | 38477 | B | M01AX25 | 1975-03-14 |
| Takrozem 1 mg/g | 67963 | B | D11AH01 | 2021-12-16 |
| Tardyferon | 37448 | D | B03AA07 | 1972-09-01 |
| Tolak 40 mg/g | 67752 | A | L01BC02 | 2021-03-02 |
Frequently asked questions
How many medicines does Pierre Fabre Pharma SA have authorised in Switzerland?
Pierre Fabre Pharma SA is recorded by Swissmedic as the authorisation holder for 27 human medicines (as of 1 September 2026). Different strengths under one authorisation number are not counted separately.
Where is Pierre Fabre Pharma SA based?
The Swiss location recorded for Pierre Fabre Pharma SA is Allschwil, Basel-Landschaft.
Is Pierre Fabre Pharma SA a Swissmedic authorisation holder?
Yes. Pierre Fabre Pharma SA appears in the official Swissmedic list of authorised medicinal products as an authorisation holder. Under the Therapeutic Products Act (TPA) the holder is responsible for the quality, safety and product information of its medicines in Switzerland.